The immuno-oncology drug developer’s prospective initial public offering would mark exits for Takeda, Merck Group, Ipsen and Merck & Co.

The fashion rental service has officially filed to go public having raised over $500m from investors including Advance Publications and American Express.

The diversified therapeutics developer has filed to go public in the United States a year after Pfizer contributed to its $310m series A round.

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

The data storage software provider has been bought by PacketFabric for an undisclosed amount, three years after a Cisco-led series A round.

Sesame Ventures helped lazy eye treatment developer Luminopia raise $12m while UPS, Qualcomm and Mercado Libre exited courier marketplace Mandaê in a purchase by Nuvemshop.

Amazon, Ford, Cox Enterprises and Abdul Latif Jameel each own stakes in the electric vehicle maker sized at 5% or higher, as it targets a reported $80bn valuation in the offering.

SoftBank invested $125m through a $160m private placement as portfolio company and cancer drug developer Exscientia went public in an offering sized at nearly $305m.

The multicorporate-backed operator of a keyless lock app called Akerun will list on the TSE’s Mothers Market next month in an IPO set to value it at $204m.

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.